NEW YORK, Aug. 1, 2011 /PRNewswire/ — Global Health Ventures
Inc. (OTCBB: GHLV), a specialty pharmaceutical company with focus
on sublingual drug delivery announced today that Dr. Hassan Salari
PhD, Chairman and CEO will be presenting at
RetailInvestorConferences.com.

DATE:  August 4, 2011

TIME:  7:00pm EDT

LINK:  www.retailinvestorconferences.com>Click
the red “register/ watch event now” button.

This will be a live, interactive online event where investors
are invited to ask the company questions in real-time both in the
presentation hall as well as the company’s “virtual trade booth.”
If attendees are not able to join the event live in real-time, an
on-demand archive will be available for 90 days.

It is recommended that investors
pre-register to save time and receive event updates.

About Global Health Ventures

Global Health Ventures (GHLV.OB) is a specialty
pharmaceutical company with expertise in drug delivery and
formulation. The Company has developed a new formulation for drug
delivery via the sublingual (under the tongue) route. This unique
method delivers drugs to the bloodstream quickly with less drug
breakdown in the liver or gastrointestinal system, a process that
can reduce side effects associated with the drugs. The Company’s
lead therapeutic product is a male sexual enhancement drug that is
delivered via sublingual route and is called X-Excite. In human
studies, X-Excite has been shown to reach the blood stream faster
than the oral route of delivery. The Company’s second drug
“Relax-B” is also under development in Canada for anxiety. And, the
third drug will be an anti-migraine drug. The Company plans to use
the same technology to deliver a vast number of other FDA approved
drugs that requi

‘/>”/>

SOURCE